Skip to content

WHNRC (Western Human Nutrition Research Center) Honey Study

WHNRC (Western Human Nutrition Research Center) Honey Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06107231
Enrollment
58
Registered
2023-10-30
Start date
2024-01-16
Completion date
2026-10-30
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Change, Metabolic Stress, Postprandial Glycemia, Satisfaction, Personal

Keywords

Satiety, Cognition, Cortisol, Glucose, Honey, Nuts, Saliva, Stool, Almonds, Sucrose

Brief summary

The purpose of this research is to compare two snacks, one with honey and nuts and the other with sugar and nuts, on glucose levels before and after eating these snacks. The investigators hypothesize that honey and nuts will have an additive effect on the reduction of postprandial glucose response. The investigators further hypothesize that consumption of honey paired with nuts will retain the benefit of sugar consumption in satiety and reduction of metabolic stress.

Detailed description

Consuming sugar creates a feeling of satiation, and may buffer metabolic stress. However, prolonged postprandial hyperglycemia has been identified as a potential risk factor in type 2 diabetes and cardiovascular disease. Nuts, which are recommended to be consumed as part of a Mediterranean diet, up to 2 servings per day, have been shown to dramatically reduce postprandial glucose response to carbohydrates. Additionally, honey, which is typically used as an added sugar within a Mediterranean diet pattern, has a lower glycemic index than table sugar and may result in a reduced postprandial glucose response relative to other nutritive sweeteners. However, it is not yet known whether honey can work additively with nuts to further reduce postprandial glucose response over the reduction caused by nuts alone. Honey has been shown to produce equivalent or greater satiety to regular table sugar and there is some indication that honey can improve immediate/working memory. Therefore, combined consumption of honey and nuts may offer a way to maximize the benefits of carbohydrate consumption on satiety and metabolic stress reduction while minimizing its negative effects on metabolism. However, it is not yet known whether sugars contained in the more complex food matrix of honey, consumed together with a food like nuts can impact satiety and metabolic stress in the way that has been observed for sugar.

Interventions

OTHERHoney

Honey representing 7% of total energy (kilocalorie) needs (40-70 grams)

OTHERSucrose

Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams)

OTHERHoney plus almonds

Honey representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)

OTHERSucrose plus almonds

Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)

Sponsors

USDA, Western Human Nutrition Research Center
Lead SponsorFED
National Honey Board
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Women must be pre-menopausal * Willing to consume snacks that contain honey, table sugar, and tree nuts

Exclusion criteria

* Body Mass Index (BMI) \<18.5 or \>40 * Allergies to tree nuts * Current medical diagnoses of chronic diseases including cardiovascular or pulmonary diseases, renal diseases, cancer, type 1 or type 2 diabetes, thyroid disease requiring medication, inflammatory or irritable bowel diseases, or those with recent major surgeries * No individuals who fall in to the vulnerable categories of adults including those unable to consent, pregnant women, children, or prisoners will be eligible for this study * Routinely taking medications known to affect glucose response. * Caffeine and alcohol use will not be excluded, but should be carefully reported by each subject. Regarding female candidates: * Post-menopausal * Women who have been pregnant or nursing within the last 6 months or plan to become pregnant during the trial will be ineligible

Design outcomes

Primary

MeasureTime frameDescription
Change in postprandial glucose responseMeasured continuously over days 0-8 and 23-31Interstitial glucose response measured by a continuous glucose monitor

Secondary

MeasureTime frameDescription
Change in Self-reported hungerFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding hunger will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Self-reported fullnessFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding fullness will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Self-reported desire to eatFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding desire to eat will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Self-reported satisfaction with snackFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding satisfaction with snack will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Self-reported prospective consumptionFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding prospective consumption will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Self-reported nauseaFasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31Responses regarding nausea will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)
Change in Cognitive testing for Spatial Working MemoryDays 4, 8, 27, and 31Cambridge Neuropsychological Test Automated battery (CANTAB) software will be used to assess Spatial Working Memory (SWM)
Change in Cognitive testing for Paired Associates LearningDays 4, 8, 27, and 31CANTAB software will be used to assess Paired Associates Learning (PAL)
Change in Cognitive testing for Rapid Visual ProcessingDays 4, 8, 27, and 31CANTAB software will be used to assess Rapid Visual Processing (RVP)
Change in Salivary cortisolDay 0 and 23 fasting only. Days 4, 8, 27, and 31 at fasting, 30, 60 and 90 min after consumption of snack provided in standard breakfastMetabolic stress will be analyzed by measuring cortisol in saliva samples
Assessment of Fasted Salivary EstradiolDays 0, 4, 8, 23, 27,and 31 at fasting onlyPassive drool will be assayed for estradiol as they impact metabolic stress throughout study days
Assessment of Fasted Salivary ProgesteroneDays 0, 4, 8, 23, 27,and 31 at fasting onlyPassive drool will be assayed for progesterone as they impact metabolic stress throughout study days
Change in Stool marker of inflammationStool collected on study days 0, 4, 8, 23, 27, and 31Fecal calprotectin measured in stool samples
Change in Stool bacterial metagenomicsStool collected on study days 0, 4, 8, 23, 27, and 31Honey responsive genes identified by metagenomics
Change in Dietary IntakeDays 1-3, 5-7, 24-26, and 28-30Food records collected using Automated Multi-pass Method (AMPM) on the platform ASA24

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMary Kable, PhD

USDA, ARS, Western Human Nutrition Research Center

PRINCIPAL_INVESTIGATORNancy Keim, PhD

USDA, ARS, Western Human Nutrition Research Center

PRINCIPAL_INVESTIGATORKevin Laugero, PhD

USDA, ARS, Western Human Nutrition Research Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026